MedTrace Logo

OM202JP Clinical Study of KNP2002

NCT05896215 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2024-09-27

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

Conditions

  • Common Wart

Interventions

DRUG

KNP2002

Dairy topical administration for 12 weeks

DRUG

Placebo of KNP2002

Dairy topical administration for 12 weeks

Sponsors & Collaborators

  • KinoPharma Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-12
Primary Completion
2024-07-27
Completion
2024-07-27

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05896215 on ClinicalTrials.gov